ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RVMD Revolution Medicines Inc

32.23
0.51 (1.61%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,038,135
Bid Price 30.83
Ask Price 33.16
News (1)
Day High 32.48

Low
15.4401

52 Week Range

High
35.60

Day Low 31.33
Company Name Stock Ticker Symbol Market Type
Revolution Medicines Inc RVMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.51 1.61% 32.23 20:00:00
Open Price Low Price High Price Close Price Prev Close
31.58 31.33 32.48 32.23 31.72
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,365 1,038,135 $ 32.06 $ 33,287,455 - 15.4401 - 35.60
Last Trade Time Type Quantity Stock Price Currency
17:12:58 formt 40,697 $ 32.23 USD

Revolution Medicines Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
29.64M 164.69M - 11.58M -436.37M -2.65 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Revolution Medicines News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RVMD Message Board. Create One! See More Posts on RVMD Message Board See More Message Board Posts

Historical RVMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week31.7032.6729.7731.25944,4110.531.67%
1 Month30.6934.5929.0031.641,712,1511.545.02%
3 Months28.4934.5925.9330.161,383,5133.7413.13%
6 Months28.8935.6015.440126.182,031,4373.3411.56%
1 Year21.0035.6015.440126.631,524,69011.2353.48%
3 Years42.6548.8114.0825.651,033,758-10.42-24.43%
5 Years29.3556.1814.0827.06865,3582.889.81%

Revolution Medicines Description

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Your Recent History

Delayed Upgrade Clock